SCANDONEST 30 mg/ml 50 cartouche 1.7 ml
7680386460440
CH-38646
N01BB03
13.01.2.
1 / 3
google
Details
- Product number
- 3864602
- CPT
- -
- Packaging group
- 50 x 1.7
- Unit
- ml
- Composition
- mepivacaini hydrochloridum 30 mg, natrii chloridum, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 2.467 mg.
Articles (1)
Scandonest 30 mg/ml, Injektionslösung
Injektionslösung
50 x 1.7
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.467 MG | Substance | HBESI |
Authorization holder
Materia Medica Maibach AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 38646
- Drug name
- Scandonest 30 mg/ml, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- N01BB03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 30/07/1975
- Authorization expiration date
- 31/12/9999
- IT number
- 13.01.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SCANDONEST 30 mg/ml 50 cartouche 1.7 ml
- Description (DE)
- SCANDONEST 30 mg/ml 50 Patrone 1.7 ml
- Market launch
- 06/11/1996
- Narcotic (BTM)
- No